Products

Human HLA-A*02:01&B2M&LMP2 Tetramer, Ultra Low Endotoxin

Overview Specification

Product Name	Human HLA-A*02:01&B2M&LMP2 Tetramer, Ultra Low Endotoxin
Cat. No.	MHCRP-0510
Category	Proteins & Peptides
Product Description	Recombinant Human HLA-A02:01&B2M&LMP2 (CLGGLLTMV) Tetramer Protein is expressed from HEK293 with His tag and Avi tag at the C-terminus, tetramer is assembled by biotinylated monomer and streptavidin. It contains Gly25-Thr305 (HLA-A02:01), Ile21-Met119 (B2M) and CLGGLLTMV peptide.
Size	100/500 μg
Format	Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Storage	Store at -20 to -80°C for 12 months as supplied from date of receipt. -80°C for 3 months after reconstitution. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Shipping Temp	Shipped with dry ice.
Lead Time	Product delivery time depends on the supplier.
Species	Human
Expression Host	HEK293
Accession No	A0A140T913(HLA-A*02:01)&P61769(B2M)&CLGGLLTMV
Tag	C-His-Avi
Tag Position	C-terminus
Molecular Type	Tetramer
Molecular Weight (MV)	The protein has a predicted MW of 258 kDa. Due to glycosylation, the protein migrates to 260-265 kDa under Non reduced (N) condition based on Bis-Tris PAGE result.
Gene Synonyms	MHC; RMF; LMP2; LMP-2; Macropain chain 7; Proteasome chain 7; PSMB9; RING12
Purity	> 95% as determined by Bis-Tris PAGE; > 95% as determined by HPLC.
Amino Acid Range	Gly25-Thr305 (HLA-A*02:01), Ile21-Met119 (B2M), and CLGGLLTMV peptide
Activity	Immobilized human HLA-A02:01&B2M&LMP2 (CLGGLLTMV) tetramer, His tag at 1 μg/mL (100 μL/well) on the plate. Dose response curve for anti-HLA-A02:01&B2M&LMP2 (CLGGLLTMV) antibody, hFc tag with the EC50 of 5.0 ng/mL determined by ELISA.
Product Background	The immunoproteasome, having been linked to neurodegenerative diseases and hematological cancers, has been shown to play an important role in MHC class I antigen presentation. The development of molecular probes that selectively inhibit the major catalytic subunit, LMP2, of the immunoproteasome, LMP2-rich cancer cells compared to LMP2-deficient cancer cells are more sensitive to growth inhibition by the LMP2-specific inhibitor, implicating an important role of LMP2 in regulating cell growth of malignant tumors that highly express LMP2.
Allele	HLA-A*02:01
Biotinylated	No

For research or industrial raw materials, not for personal medical use!